- CATX Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
10-K/A Filing
Perspective Therapeutics (CATX) 10-K/A2012 FY Annual report (amended)
Filed: 26 Oct 12, 12:00am
Exhibit 21
SUBSIDIARIES OF THE REGISTRANT
IsoRay Medical, Inc., a Delaware corporation
IsoRay International LLC, a Washington limited liability company
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Dated: October 25, 2012
ISORAY, INC., a Minnesota corporation
By /s/ Dwight Babcock
Dwight Babcock, Chief Executive Officer and Chairman
By /s/ Brien L. Ragle
Brien L. Ragle, Controller,
Principal Financial and Accounting Officer
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
Dated: October 25, 2012
/s/ Dwight Babcock
Dwight Babcock, Chief Executive Officer and Chairman
/s/ Brien L. Ragle
Brien L. Ragle, Controller,
Principal Financial and Accounting Officer
/s/ Robert Kauffman
Robert Kauffman, Director and Vice-Chairman
/s/ Thomas LaVoy
Thomas LaVoy, Director
/s/ Albert Smith
Albert Smith, Director